您的位置: 首页 > 农业专利 > 详情页

HER2/neu cancer vaccine
专利权人:
Icon Genetics GmbH;University of Southampton
发明人:
Savelyeva, Natalia,Jarczowski, Franziska,Kandzia, Romy,Nickstadt, Anja,Thieme, Frank,Klimyuk, Victor,Gleba, Yuri,Bui-Minh, Duc,Stevenson, Freda K.,Chotprakaikiat, Warayut
申请号:
AU2014231214
公开号:
AU2014231214B2
申请日:
2014.03.11
申请国别(地区):
AU
年份:
2018
代理人:
摘要:
Protein conjugate comprising a protein antigen for generating an immune response against the HER2/neu protein and an immunogenic carrier covalently bonded to said protein antigen, wherein said protein antigen (i) has a sequence segment of 300 or more contiguous amino acids of the amino acid sequence of SEQ ID NO: 1; or (ii) has a variant sequence segment of 300 or more amino acid residues, wherein the amino acid sequence of said variant sequence segment has at least 85% sequence identity to a sequence portion from SEQ ID: 1; or (iii) has a variant sequence segment of 300 or more amino acid residues and has from 1 to 10 substitutions, deletions or additions in said variant sequence segment compared to a sequence segment of 300 or more amino acid residues of the amino acid sequence of SEQ ID NO: 1 or 2.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充